Tag - pfizer

 
Menu
Search
 
November 24, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

PFIZER

Japan Times
ASIA PACIFIC
Nov 8, 2021
South Korea to purchase 70,000 courses of new Pfizer COVID-19 pill
Pfizer has said trial results showed that its Paxlovid pill reduced by 89% the risk of hospitalization or death in some patients.
Japan Times
COMMENTARY / World
Nov 7, 2021
COVID-19 drugs will change the way we live with the virus
New COVID-19 drug approvals couldn't be timelier as hospitals face massive backlogs of delayed procedures.
Japan Times
WORLD / Science & Health / ANALYSIS
Nov 6, 2021
Pfizer results open door to new chapter for COVID treatments
The world needs an easy-to-take COVID-19 treatment. Pfizer Inc.'s and Merck & Co. Inc.'s new pills may be just that. But questions remain about their safety and how well they will work.
Japan Times
WORLD / Science & Health
Nov 5, 2021
Pfizer develops COVID-19 pill that cuts hospitalizations and deaths by 89%
The drugmaker claims 'overwhelming efficacy” and plans to submit their findings for emergency authorization as soon as possible.
Japan Times
WORLD
Oct 30, 2021
Pfizer won the first round, but Moderna sees final victory ahead
Pfizer has been first across the finish line in nearly every leg of the COVID-19 vaccine race, but Moderna executives say their company's mRNA technology gives it an advantage.
Japan Times
JAPAN / Science & Health
Oct 28, 2021
Pfizer to seek OK for use of COVID-19 shot in children in Japan age 5 to 11
The government is hinting that it will act swiftly to make the vaccine available to children in that demographic.
Japan Times
JAPAN / Science & Health
Oct 14, 2021
Japan may recommend Pfizer's COVID-19 shot over Moderna's for men under 30
Even as concerns grow about higher rates of myocarditis among young men who got the Moderna shot, the risk of developing the heart condition is still much lower than after getting COVID-19.
Japan Times
WORLD
Oct 8, 2021
Pfizer seeks U.S. COVID-19 vaccine clearance for children age 5 to 11
The Food and Drug Administration has set a date of Oct. 26 for its panel of outside advisers to meet and discuss the application.
Japan Times
ASIA PACIFIC
Sep 30, 2021
China's vaccine diplomacy drive falters as recipients turn to western shots
In the early days of COVID-19 vaccine rollouts, Chinese shots saved countless lives. But as the Western stranglehold on mRNA supplies loosens, a clear preference has emerged.
Japan Times
COMMENTARY / World
Sep 29, 2021
Liars may get COVID-19 boosters before those in need
Who will get the booster shots? Sadly, the answer is too many of the wrong people and too few of the right ones, adding more messiness to the rollout process.
Japan Times
WORLD
Sep 29, 2021
Pfizer submits COVID-19 vaccine data to U.S. regulators for use in younger kids
A Pfizer spokesperson said the company expects to start and complete its application very soon.
Japan Times
WORLD / Science & Health
Sep 24, 2021
U.S. CDC advisers back COVID-19 booster shots for older people but not for high-risk workers
Beyond older Americans, the committee also recommended the shots for all adults over 50 with underlying conditions, as well as some 18- to 49-year-olds with those conditions.
Japan Times
WORLD
Sep 20, 2021
Pfizer COVID-19 shot safely bolsters antibodies in younger kids
In a trial, two shots of a 10 microgram dose — one-third of the adult shot — produced antibody levels comparable to those seen in a trial of 16- to 25-year-olds who got the adult dose.
Japan Times
WORLD
Sep 20, 2021
Pfizer shot’s protection against hospitalization wanes in study
After four months, Moderna's vaccine was 92% effective against hospitalization, with Pfizer's at 77% and Johnson & Johnson's at 68%.
Japan Times
JAPAN
Sep 14, 2021
Japan to donate 1.3 million more AstraZeneca vaccine doses to Taiwan and Asian neighbors
Taiwan will get 500,000 more doses, bringing Japan's total donation to the island to 3.9 million, Foreign Minister Toshimitsu Motegi told reporters.
Japan Times
COMMENTARY / World
Sep 8, 2021
Vaccines versus COVID-19: The great immunity debate
People who don’t want to get vaccinated will grasp at any new piece of information to justify their reluctance — the latest being some pretty good data suggesting that the natural immunity left after recovering from COVID-19 is stronger over the long run than immunity generated by the Pfizer vaccine....
Japan Times
WORLD / Science & Health
Sep 5, 2021
The Moderna vaccine makes more antibodies than Pfizer's. Does it matter?
Subtle differences between the Pfizer Inc.-BioNTech SE and Moderna Inc. vaccines are emerging across patient groups over time, but what this all means in the real world is still unclear.
Japan Times
WORLD / Science & Health / ANALYSIS
Sep 3, 2021
Vaccine advisers to U.S. FDA face thorny question: Are COVID-19 boosters needed?
A fierce debate is expected around whether most Americans should get another shot rather than just those at high risk of severe illness.
U.S. aircraft carrier returns to Japan carrying navy’s ‘most capable fighter’
U.S. 7th Fleet Commander Vice Adm. Fred Kacher speaks to reporters shortly after the arrival of aircraft carrier USS George Washington at Yokosuka naval base in Kanagawa Prefecture on Friday.
After Shohei Ohtani bump, Iwate ironware maker sees brighter future
Kaito Kikuchi's decision to send superstar Shohei Ohtani one of his company's traditional ironware tea kettles has paid off with a surge of interest from general consumers.
Japan approves ¥21.9 trillion stimulus plan
The policy chiefs of the Democratic Party for the People, Liberal Democratic Party and Komeito — Makoto Hamaguchi (left), Itsunori Onodera (center) and Mitsunari Okamoto — shake hands after reaching an agreement on an economic stimulus package on Wednesday.
Woman dies after train collides with car in Tochigi
A Moka Railway train car
Japan will spend ¥325 million in government funds on Princess Yuriko's funeral
Princess Yuriko waves during the New Year's public greeting at the Imperial Palace in Tokyo in January 2019.
133-year-old Kyushu railway station remains to be partially preserved
The remains of the original Moji Station in Kitakyushu
After Shohei Ohtani bump, Iwate ironware maker sees brighter future
Kaito Kikuchi's decision to send superstar Shohei Ohtani one of his company's traditional ironware tea kettles has paid off with a surge of interest from general consumers.
Shohei Ohtani wins National League MVP award
Shohei Ohtani celebrates after hitting a three-run home run against the Padres during the National League Division Series at Dodger Stadium in Los Angeles last month.
The slow-burn success of ‘A Samurai in Time’
A 19th-century warrior gets struck by lightning and wakes to find himself in 21st-century Kyoto in Junichi Yasuda’s surprise hit “A Samurai in Time.”
Around a quarter of Japan married couples in their 20s met through dating apps
A survey released by an organization promoting “Good Couples Day” shows that 24% of couples in their 20s met their marriage partner through a dating app.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?
By Kathryn Wortley

SUSTAINABLE JAPAN

mission sustainability vol.12 : Kose Corp.Kose takes pride in creating beauty in the world
mission sustainability vol.12 : Kose Corp.Kose takes pride in creating beauty in the world

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER